Search

A recent study conducted by researchers at Sichuan University in Chengdu, China, explored the potential anti-breast-cancer effects of Rosa sterilis (RS) juice. The study found that RS juice inhibited cell proliferation, affected cell morphology, and promoted apoptosis in breast cancer cells. In addition, RS juice suppressed the Jak2/Stat3 signaling pathway, both in vitro and in vivo. The findings suggest that RS juice may have protective effects against breast cancer by triggering the mitochondrial apoptosis pathway and suppressing the Jak2/Stat3 pathway. This research provides new dietary intervention strategies for breast cancer. [Extracted from the article]

A recent study conducted by researchers at Hunan University of Chinese Medicine in Changsha, China, explores the potential anti-inflammatory effects of polysaccharides found in traditional Chinese medicines. Chronic inflammation is associated with various diseases, and current anti-inflammatory drugs often have adverse effects. Polysaccharides from medical and edible homologous traditional Chinese medicines (MEHTCMs) have shown promise as natural anti-inflammatory drugs. However, the structures and structure-efficacy relationship of these polysaccharides are not fully understood, which presents challenges in their development as anti-inflammatory drugs. The study examines the potential mechanisms and evaluates the relationship between the anti-inflammatory activity of MEHTCM polysaccharides and their structures. [Extracted from the article]

A report from Guangdong Provincial People's Hospital in China has identified a novel immune-related long non-coding RNA (lncRNA) as a potential prognostic biomarker for HER2-positive breast cancer. The study used data from The Cancer Genome Atlas and The Immunology Database and Analysis Portal to identify differentially expressed lncRNAs and immune-related genes. The researchers found that the expression of lncRNA CTC-537E7.2 was significantly correlated with patient survival and clinical parameters, suggesting its potential as a prognostic marker. Further research is needed to investigate the underlying molecular mechanisms driving the development of this subtype of breast cancer. [Extracted from the article]

A recent study conducted by researchers at Tekirdag Namik Kemal University investigated the effects of trimetazidine (TMZ) on ovarian ischemia/reperfusion (I/R) injury in rats. The study found that TMZ administration protected against I/R injury by reducing oxidative stress and inflammation. The researchers also observed improvements in biochemical, molecular, and histopathological markers. These findings suggest that TMZ may be a potential treatment for ovarian I/R injury. Further research is needed to explore this new pathway and its implications for women's health. [Extracted from the article]

A preprint abstract suggests that current drug treatments for epilepsy only treat symptoms and do not provide disease modification. However, a study using rodent models and human samples found that brief inhibition of the JAK/STAT pathway with the drug CP690550 (Tofacitinib) can suppress seizures, improve spatial memory, and reverse neuropathological alterations. The effects of seizure suppression lasted for at least 2 months after the last dose. This research provides a potential avenue for disease modification in epilepsy using an FDA-approved drug. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted at the Peter MacCallum Cancer Center in Melbourne, Australia, has identified resistance mechanisms to small-molecule inhibition of Tead-regulated transcription in lung cancer and mesothelioma. The study found that mutations in genes from the Hippo, MAPK, and JAK-STAT signaling pathways can modulate the response of mesothelioma cell lines to TEAD palmitoylation inhibitors. Additionally, the study revealed that combined inhibition of TEAD and the MAPK kinase MEK can synergistically block proliferation of mesothelioma and lung cancer cell lines and reduce the growth of patient-derived lung cancer xenografts. These findings provide insights into potential strategies to enhance the anti-tumor activity of emerging Hippo pathway targeted therapies. [Extracted from the article]

A recent study conducted at the University of California has found that JAK inhibition with tofacitinib can rapidly increase contractile force in human skeletal muscle. The study involved muscle biopsies from patients who were given either tofacitinib or a placebo for 48 hours. The results showed that the contractile force of the muscle fibers in the tofacitinib group was significantly higher than those in the placebo group. The researchers believe that JAK inhibition could be a potential new therapy for muscle dysfunction in various clinical conditions. [Extracted from the article]

A recent study investigated the genetic and expression profiles of Inflammatory Bowel Disease (IBD) and its subtypes, Crohn's disease (CD) and Ulcerative Colitis (UC). The study analyzed data from genome-wide association studies (GWAS) and gene expression data to identify shared and unique genetic factors among these conditions. The study found that genes associated with IBD are expressed not only in the gastrointestinal tract but also in various regions of the brain, suggesting potential links between IBD and neurological functions. Additionally, the study revealed a shared genetic architecture between IBD and several neurological disorders, such as schizophrenia, depression, autism spectrum disorder, and attention-deficit/hyperactivity disorder. These findings highlight the systemic nature of IBD and its potential neurological implications, which could inform targeted therapeutic strategies. [Extracted from the article]

A report from Fujian Normal University in Fuzhou, China, discusses the potential of Yadanziolide A (Y-A), a natural derivative of Brucea javanica, as a treatment for liver cancer. The study found that Y-A demonstrated dose-dependent cytotoxic effects on liver cancer cells, inhibiting proliferation, migration, and invasion. It also induced apoptosis and inhibited tumor growth in mouse models. The researchers concluded that Y-A has promising anticancer activity and potential utility in liver cancer therapy. Further research is needed to explore its efficacy and underlying mechanisms. [Extracted from the article]

Researchers from Anhui Medical University have conducted a study on bladder cancer, focusing on the phosphatidylinositol-3-OH kinase (PI3K) signaling pathway. They found that inhibiting PI3K showed promising anti-tumor effects in both in vitro and in vivo settings. However, the feedback activation of the JAK1-STAT3 signaling pathway led to resistance against the PI3K inhibitor. The researchers suggest that a combinational therapeutic approach targeting both PI3K and STAT3 pathways could be effective in treating bladder cancer. This study provides valuable insights into potential treatment strategies for bladder cancer. [Extracted from the article]

A recent study conducted by researchers at Zhongnan Hospital of Wuhan University in China explored the effects of folic acid-modified liposome quercetin (FLQ) on triple-negative breast cancer (TNBC) cells. The study found that FLQ inhibited the proliferation and promoted the apoptosis (cell death) of TNBC cells. This effect was attributed to the activation of the mitochondrial apoptosis pathway through the inhibition of the JAK2/STAT3 signaling pathway. These findings suggest that FLQ may have potential as a treatment for TNBC. [Extracted from the article]

Researchers from the Medical University of Lublin in Poland have conducted a study on acute lymphoblastic leukemia (ALL), a type of cancer that primarily affects children. The study focused on the role of the JAK-STAT pathway in the development of childhood B-cell ALL. Genetic aberrations, such as mutations in certain genes, can lead to malfunction of this pathway, which is involved in important biological processes. The researchers suggest that understanding these mechanisms could potentially lead to the development of drugs targeting the components of the JAK-STAT pathway. Some existing drugs that interfere with this pathway include fludarabine, ruxolitinib, and fedratinib. [Extracted from the article]

A recent study conducted by researchers at the First Affiliated Hospital of Gannan Medical University explores the role of leukocyte immunoglobulin-like receptor B4 (LILRB4) in aortic dissection (AD), a life-threatening condition with limited treatment options. The study utilized animal models and in vitro assays to investigate the effects of LILRB4 knockdown on AD development. The findings suggest that LILRB4 knockdown inhibits AD development by regulating pyroptosis (a form of cell death) and the JAK2/STAT3 signaling pathway. The study provides insights into potential therapeutic targets for AD treatment. [Extracted from the article]

A study conducted at Southern Medical University investigated the effects of treadmill training on neural function recovery in rats with spinal cord injury (SCI). The researchers found that rats in the treadmill training group showed improved spinal cord function compared to the control group. They also observed that the JAK2/STAT3 signaling pathway was activated and apoptosis was attenuated in the treadmill training group. These findings suggest that treadmill training may enhance functional recovery in SCI by activating the JAK2/STAT3 pathway and reducing apoptosis. [Extracted from the article]

A recent study conducted by researchers at Anhui University of Traditional Chinese Medicine in Hefei, China, explored the effects of cryptotanshinone (CPT) on gastric cancer cells. The study found that CPT inhibited the growth of 5-fluorouracil-resistant gastric cancer cells and induced apoptosis. The researchers also discovered that CPT decreased the expression of certain genes related to cell survival and increased the expression of a gene associated with cell death. Additionally, CPT enhanced the inhibitory effect of 5-fluorouracil on the cancer cells. The findings suggest that CPT may have potential as a treatment for gastric cancer. [Extracted from the article]

A recent study conducted by researchers at the University of South China in Hengyang, People's Republic of China, has investigated the role of microRNAs (miRNAs) and circular RNAs (circRNAs) in pulmonary fibrosis induced by beryllium sulfate (BeSO4). The study found that elevated expression of hsa-miR-663b and knockdown of hsa#95;circ#95;0004214 attenuated the epithelial-mesenchymal transition (EMT) induced by BeSO4 through the inhibition of the JAK-STAT signaling pathway. These findings suggest that hsa-miR-663b and hsa#95;circ#95;0004214 could serve as potential therapeutic targets for chronic beryllium disease. The study was funded by the Natural Science Foundation of Hunan Province and the Hunan Provincial Innovation Foundation for Postgraduate. [Extracted from the article]

A recent study conducted at the Affiliated Hospital of Nantong University investigated the cardioprotective effects of L-theanine in myocardial ischemia-reperfusion injury (MIRI). The researchers found that L-theanine administration suppressed cellular apoptosis and oxidative stress in mice with MIRI by activating the JAK2/STAT3 signaling pathway. This resulted in a decrease in cardiac damage and could potentially be developed as a drug to alleviate cardiac injury in MIRI. The study provides valuable insights into the potential therapeutic applications of L-theanine in cardiovascular diseases. [Extracted from the article]

A recent study conducted at Guangdong Pharmaceutical University in China explored the potential therapeutic effects of eugenol, a compound derived from certain plants, on non-small cell lung cancer (NSCLC). The researchers found that eugenol exhibited anti-angiogenic effects, meaning it inhibited the growth of new blood vessels that are crucial for tumor progression. It also blocked specific signaling pathways involved in NSCLC. These findings suggest that eugenol could be a promising treatment option for NSCLC by targeting angiogenesis. [Extracted from the article]

A recent study from the Rheumatology Unit provides an update on the current management strategies for giant cell arteritis (GCA). The study emphasizes the need for alternative therapies to reduce disease relapses and mitigate the side effects of glucocorticoid (GC) treatment. The efficacy of tocilizumab (TCZ), an interleukin-6 receptor inhibitor, in reducing disease flares and sparing GCs has been highlighted in randomized clinical trials. However, the optimal treatment duration with TCZ is still unknown, and there is a need for alternative therapies for patients who are not candidates for TCZ or have an inadequate response. While GCs remain the cornerstone of therapy, ongoing research targeting different pathways implicated in GCA pathogenesis has shown promising results, but larger randomized controlled trials are needed to establish their efficacy conclusively. [Extracted from the article]

A study conducted by researchers at Nanchang University in China explored the anti-inflammatory effects of bound polyphenols derived from the insoluble dietary fiber of navel orange peel (BPP) on LPS-induced RAW264.7 macrophages. The study found that BPP effectively suppressed COX-2 and iNOS protein expression, reduced intracellular ROS production and NO release, and inhibited key proteins in the NF-kappa B and JAK-STAT pathways. These findings suggest that BPP has potential as a natural anti-inflammatory agent and could be used in functional food applications. The research was supported by the National Natural Science Foundation of China. [Extracted from the article]

Breast cancer is the most common malignant tumor in women worldwide, with a higher incidence in Sub-Saharan Africa compared to high-income countries. In Kenya, breast cancer is the most commonly diagnosed cancer among women. Research suggests that women receiving breast cancer treatment are at a higher risk of developing hypertension. The JAK-STAT signaling pathway, which is activated in hormone receptor-positive breast tumors, may play a role in the development of hypertension among Kenyan women with breast cancer. This study identified specific genes within the JAK-STAT pathway that were dysregulated in breast tumor tissues and correlated with elevated blood pressure and heart rate. Further research is needed to validate these findings and develop targeted treatments for Kenyan women with breast cancer and hypertension. [Extracted from the article]

A research study conducted at Guangxi University explores the role of the immune receptor TREM2 in renal injury, specifically in cases of unilateral ureteral obstruction (UUO) or ischemia-reperfusion injury (IRI)-induced renal injury. The study found that TREM2 deficiency worsened renal inflammation and fibrosis in mice with UUO, along with increased macrophage apoptosis and polarization. The deficiency also promoted M1 and M2 polarization via the JAK-STAT pathway, affecting cell survival. These findings suggest that TREM2 plays a role in the regulation of renal injury and warrant further investigation. [Extracted from the article]

A recent study conducted by researchers at Inner Mongolia University of Science and Technology has found that puerarin, a compound found in traditional Chinese medicine, may be effective in treating osteoporosis in rats. The study involved rats that underwent ovariectomy to simulate postmenopausal osteoporosis and were then treated with puerarin. The results showed improved bone density and reduced bone loss in the rats treated with puerarin, along with increased levels of bone formation markers. The study also found that puerarin inhibited the activation of the JAK2/STAT3 signaling pathway in bone tissue. These findings suggest that puerarin may combat osteoporosis by promoting osteogenesis and inhibiting the JAK2/STAT3 pathway. [Extracted from the article]

A recent study conducted by researchers at Lanzhou University in Gansu, China, has found that salidroside, a natural compound, may have anti-aging effects and could potentially improve cellular senescence in chronic obstructive pulmonary disease (COPD). The study involved treating human bronchial epithelial cells with cigarette smoke extract and evaluating the effects of salidroside on cellular senescence. The results showed that salidroside reduced cellular senescence by inhibiting the JAK2/STAT3 signaling pathway, suggesting that it could be a novel strategy for COPD treatment. This research has been peer-reviewed and provides valuable insights into potential therapeutic approaches for COPD. [Extracted from the article]

A report from New York University (NYU) provides new insights into the cardiovascular risk management of patients treated with Janus kinase inhibitors (JAKi). The study highlights the potential risk of venous thromboembolism and cardiovascular events associated with JAKi therapy, particularly with the oral JAKi, tofacitinib. The research suggests a comprehensive and systematic approach for evaluating cardiovascular risk in patients considering JAKi therapy, emphasizing the role of cardiologists in risk stratification and mitigation for patients with high cardiovascular risk factors or on long-term JAKi therapies. The study was supported by the NIH National Center for Advancing Translational Sciences (NCATS). [Extracted from the article]

A recent study conducted by researchers at Xi'an Jiaotong University Health Science Center has found that a protein called Testis specific protein, Y-encoded-like 2 (TSPYL2) plays a role in sustaining high blood pressure in hypertensive rats. The study focused on the hypothalamic paraventricular nucleus (PVN) and found that TSPYL2 interacts with the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway to maintain hypertension. Knockdown of TSPYL2 led to reduced blood pressure and deactivation of JAK2/STAT3, while inhibition of JAK2/STAT3 also reduced blood pressure. These findings suggest that TSPYL2 and JAK2/STAT3 could be potential therapeutic targets for hypertension. [Extracted from the article]

Researchers from Sun Yat-sen University in Guangzhou, China have conducted a study on oncolytic virotherapy, a type of cancer treatment that uses viruses to selectively infect and kill cancer cells. The study focused on the pharmacokinetic properties of the oncolytic virus M1 (OVM) and identified the JAK-STAT pathway as a key modulator of its pharmacokinetics. By inhibiting this pathway, the researchers found that the pharmacokinetics of OVM were improved, leading to enhanced tumor-specific viral accumulation and improved antitumor efficacy. The study provides insights into the relationship between pharmacokinetics and antitumor efficacy in oncolytic virotherapy. [Extracted from the article]

A study conducted by researchers at Nanjing Agricultural University in Jiangsu, China, has found that deoxynivalenol (DON), a mycotoxin commonly found in food and cereals, can aggravate inflammation at non-cytotoxic concentrations. The study used an IL-10 gene-silenced RAW264.7 cell model and found that a non-cytotoxic concentration of DON at 25 ng/ml increased inflammation by increasing IL-1 beta and TNF-alpha mRNA expression, migration and phagocytosis, and enhancing JAK2/STAT3 phosphorylation. The study suggests that non-cytotoxic concentrations of DON could worsen inflammation when IL-10 knockdown is present, highlighting the need for vigilance against low-level DON contamination in the presence of inflammation. [Extracted from the article]

A recent study conducted by researchers at Wenzhou Medical University in China explored the potential benefits of patchouli alcohol (PatA) in protecting the heart against diabetes-related cardiomyopathy (DCM). The study found that PatA treatment in mice with type 1 diabetes resulted in the protection of the heart against cardiomyopathy by controlling myocardial fibrosis. The researchers also discovered that PatA may target the Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway to mitigate the effects of high glucose and palmitic acid-induced fibrotic and inflammatory responses. These findings suggest that PatA could potentially be used as a therapeutic agent for DCM treatment. [Extracted from the article]

A study conducted at the Federal University Sao Paulo in Brazil aimed to analyze potential changes in the ocular cells of fetuses from mothers with insulin resistance who were exposed to saturated fatty acids during pregnancy. Female Wistar rats were induced to develop insulin resistance before pregnancy, and the fetuses' skulls were collected on the 20th day of intrauterine life. The study's findings were published in the Revista da Associacao Medica Brasileira. For more information, readers can contact Daniel Araki Ribeiro at the Federal University Sao Paulo. [Extracted from the article]

A recent study conducted at Chengdu Sport University investigated the effects of endurance training on sarcopenia, a condition characterized by a decrease in muscle function, mass, and strength due to aging. The researchers found that endurance training effectively improved muscle function, mass, and strength in mice with sarcopenia. They also identified the JAK2/STAT3 pathway as a possible mechanism for the improvement of sarcopenia through endurance training. The study suggests that endurance training may be a promising intervention for sarcopenia, but further research is needed to fully understand the underlying mechanisms. [Extracted from the article]

A patent has been issued for 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors. JAK2 is a non-receptor tyrosine kinase involved in cell processes such as immunity, cell division, and cell death. Dysfunctions in the JAK-STAT signaling pathway, which JAK2 is a part of, are implicated in various diseases including cancer, autoimmune diseases, and inflammatory conditions. The patent provides compounds that can inhibit JAK2 and potentially be used for treating and preventing diseases associated with JAK2. The patent was filed by Ajax Therapeutics Inc. and published online on April 30, 2024. [Extracted from the article]

A report from Zhengzhou University People's Hospital in Henan, China explores the mechanism by which the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway promotes lymph node metastasis in cervical cancer based on CD8+ T cell senescence. The study found that the JAK-STAT pathway is activated in cervical cancer and contributes to tumor growth and metastasis, as well as influencing the senescence of CD8+ T cells. Inhibition of the JAK-STAT pathway can delay the senescence of CD8+ T cells, weaken the biological behavior of cervical cancer cells, and inhibit tumor metastasis. [Extracted from the article]

Researchers in Bucharest, Romania have conducted a scoping review on the use of Janus Kinase inhibitors (JAKis) in the treatment of psoriasis and psoriatic arthritis. Psoriasis is a common dermatological disease associated with systemic inflammation, and around 20% of patients also experience joint involvement. The introduction of biologic treatments for psoriasis has been a significant advancement, but JAKis offer a new class of orally administered molecules that may benefit patients who have not responded to biologic therapy. This study provides an integrated understanding of the effects of JAKis on the whole spectrum of psoriasis manifestations. [Extracted from the article]

A recent study conducted by researchers at Beijing University of Chinese Medicine explores the relationship between lymphocyte homing and the pathogenesis of Sjogren's syndrome (SS), a chronic autoimmune disease. The study highlights the importance of chemokines, chemokine receptors, and lymphocyte homing receptors in the migration of inflammatory cells to the affected glands and the formation of ectopic germinal centers in SS. The findings have led to the development of potential targeted therapies for SS, including antibodies to cell adhesion molecules, chemokine receptor antagonists, compounds interfering with chemokine receptor signaling, and gene therapies targeting chemokines and their receptors. This research provides valuable insights into the treatment of SS and offers new targets for intervention. [Extracted from the article]

A recent report from the University of South China highlights the potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer (TNBC). TNBC is a challenging form of breast cancer due to its tendency to metastasize and poor prognosis. The JAK2/STAT3 pathway plays a role in evading the immune system and is highly active in certain subtypes of TNBC. Targeting this pathway with small molecule compounds is being investigated as a promising therapeutic strategy for TNBC treatment. The goal is to develop novel compounds that effectively target TNBC and enhance therapeutic efficacy for patients. [Extracted from the article]

Scientists from Vienna have discovered that immune cells are constantly stimulated by healthy tissue, which keeps them active and ready to respond to pathogens. This insight could lead to the development of medications that selectively enhance the immune system's attention. The study, published in the journal Nature Immunology, found that the same JAK-STAT signaling pathway that activates immune cells during an infection also keeps them on standby when no pathogens are present. Understanding how immune cells maintain this balance could have implications for autoimmune diseases and future therapies. [Extracted from the article]

This article discusses a potential new treatment for interstitial cystitis (IC), a chronic inflammatory disorder that causes severe pain in the bladder and surrounding areas. The researchers propose a nanocluster-antibody-drug conjugate (NADC) that combines dihydroorotate dehydrogenase inhibitors (DHODHi) and ultrasmall gold quantum clusters (AuQCs) with a nerve growth factor (NGF) antagonistic antibody. The NADC is designed to provide diagnostic and therapeutic benefits, including X-ray computed tomographic and near-infrared fluorescence imaging contrasts. In animal models, the NADC effectively reduced inflammation and modulated cytokine levels, potentially offering a new approach for diagnosing and treating IC. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

A research study conducted in Chongqing, China, focused on lupus nephritis (LN), a complication of systemic lupus erythematosus (SLE). The study aimed to identify oxidative stress (OS)-related genes associated with LN and explore their diagnostic and therapeutic potential. Using machine learning and gene expression analysis, the study identified four hub genes (STAT1, PRODH, TXN2, and SETX) that were associated with OS in LN. These genes were validated for their diagnostic potential and their involvement in LN pathogenesis. The study's findings contribute to understanding the complex relationship between OS, immune dysregulation, and molecular pathways in LN, providing a foundation for potential diagnostic biomarkers and therapeutic targets. [Extracted from the article]

A recent study conducted at the Affiliated Hospital of Southwest Medical University in Luzhou, China, used bioinformatics to identify biomarkers and immunoinflammatory targets in children with cerebral palsy (CP). CP is a common disabling disease in children, characterized by motor dysfunction. The study found that the molecular mechanism of CP is not well understood, but bioinformatics analysis revealed key biomarker-related signaling pathways involved in immune response, neurogenesis, and inflammation. The findings suggest that immune cells and inflammatory factors play a significant role in the development and progression of CP. Further research is needed to better understand the pathophysiology of CP and develop targeted interventions. [Extracted from the article]

Researchers at the CSIR - Indian Institute of Integrative Medicine have discovered a novel and highly selective JAK3 inhibitor, called MJ04, that shows potential as a hair growth promoter. The inhibitor demonstrated promising results in in vivo and in vitro efficacy assays, promoting hair regrowth in mice and human hair follicles. The researchers believe that MJ04 has suitable properties for topical drug development and could advance to human clinical trials. This research provides new insights into the use of JAK-STAT signaling pathway inhibitors for the treatment of hair loss. [Extracted from the article]

Researchers from Sichuan University have presented data on cervical cancer vaccines. The study focused on the immunosuppressive status prevalent in cancer patients and its impact on tumor immunotherapy. The researchers found that Listeria-vectored tumor vaccines had a two-sided regulatory effect on the immune response, improving the antitumor immune response and inhibiting the suppressive immune response in tumor-bearing mice. The vaccines reduced the expression of myeloid-derived suppressor cells (MDSCs) and inhibited the phosphorylation level of STAT3 protein, which is involved in MDSCs differentiation. This research provides insights into breaking immunosuppression in cervical cancer immunotherapy. [Extracted from the article]

A recent study conducted by researchers at Universita degli Studi di Milano in Italy explored the role of leptin, an appetite-regulating hormone, in anorexia nervosa (AN). The study used a rat model of anorexia and found that leptin levels were reduced in adolescent female rats with anorexia. The researchers also observed changes in the leptin signaling pathway in the hippocampus, a brain region involved in spatial memory and emotion regulation. These findings provide new insights into the mechanisms underlying anorexia and may contribute to a better understanding of the disorder. [Extracted from the article]

A study conducted in Shannxi, People's Republic of China, focused on the role of Extra spindle-polar body like 1 (ESPL1) in bladder cancer progression and cisplatin resistance. The researchers found that ESPL1 was highly expressed in bladder cancer tumor tissues and cells, particularly in cisplatin-resistant tissues or cells. They also discovered that PAX2-mediated ESPL1 transcriptional activation contributed to cisplatin resistance by activating the JAK2/STAT3 pathway. Silencing ESPL1 or combining it with cisplatin treatment inhibited tumor growth in a xenograft tumor model. This study provides insights into potential therapeutic targets for bladder cancer treatment. [Extracted from the article]

A research report from the University of Cagliari in Italy discusses the role of two endogenous lipids, oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), in neuroblastomas. The study investigates the effects of OEA and PEA on human neuroblastoma cells treated with type I interferons (IFNs), which are used in the treatment of various cancers. The researchers found that co-exposure to OEA or PEA with IFNb led to increased apoptotic cell death and decreased cell survival and proliferation. The study also revealed a novel mechanism by which OEA and PEA can impair cell survival through modulating the intrinsic apoptotic pathway. [Extracted from the article]

Researchers from the University of Tehran have conducted a study on the protective effects of hepatic ischemic post-conditioning (IPOC) against injury induced by ischemia/reperfusion (IR) in the liver. The study aimed to investigate the role of the interleukin 6-Janus kinase-signal transducers and activators of transcription (IL-6-JAK-STAT) pathway in this protective effect. The results showed that hepatic IPOC improved liver injury induced by IR, as evidenced by histological changes, reduction of IL-6 level, and decreased enzyme release. The study suggests that the protective effect of hepatic IPOC may be mediated by activating the IL-6-JAK-STAT pathway. [Extracted from the article]

A recent report from Nanjing University of Chinese Medicine in China explores the effects of Jiawei Tangzhiqing granules on the JAK2/STAT3 signaling pathway and Th17/Treg ratio in mice with diabetic nephropathy (DN). The study found that the granules reduced renal damage in DN by suppressing the JAK2/STAT3 signaling pathway and correcting the Th17/Treg ratio imbalance. These findings suggest that Jiawei Tangzhiqing granules may have a potential therapeutic role in managing DN. Further research is needed to investigate the correlation between the Th17/Treg balance and the JAK2/STAT3 signaling pathway. [Extracted from the article]

A recent study conducted at the University of Electronic Science and Technology of China explored the role of Galectin 2 (LGALS2) in oral squamous cell carcinoma (OSCC). The researchers found that lower levels of LGALS2 were associated with OSCC tumor tissue samples and were linked to clinicopathological characteristics and patient survival outcomes. Silencing LGALS2 increased proliferation in OSCC cells and made them more resistant to apoptosis, while overexpressing LGALS2 had the opposite effect. The study suggests that LGALS2 may act as a suppressor of OSCC progression by modulating the JAK/STAT3 signaling pathway, making it a potential target for treating OSCC patients. [Extracted from the article]

A recent study conducted at Peking University Third Hospital in Beijing, China, has found that Nitazoxanide (NTZ), an FDA-approved anti-parasitic drug, may have potential as a preventive treatment for rheumatoid arthritis (RA). The study used primary RA fibroblast-like synoviocytes (RA-FLS) and a collagen-induced arthritis (CIA) murine model to evaluate the effects of NTZ. The results showed that NTZ inhibited the proliferation, migration, and invasion capacity of RA-FLS, reduced the expression of inflammatory mediators, and ameliorated synovial inflammation and bone erosion in mice. These findings suggest that NTZ could be a promising therapeutic agent for RA. [Extracted from the article]

A study conducted by researchers from Fudan University in Shanghai, China explored the potential of Curcumae Rhizoma in treating prostate cancer using network pharmacology. The researchers identified six active ingredients in Curcumae Rhizoma and 96 targets associated with prostate cancer. They found that these active ingredients exert anti-tumor effects by regulating specific target genes and affecting important pathways. This study provides new insights into the potential mechanism of Curcumae Rhizoma in treating prostate cancer and paves the way for further research in this field. [Extracted from the article]